Peter L. Perrotta

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Detecting SARS-CoV-2 Orf3a and E ion channel activity in COVID-19 blood samples”.

Detecting SARS-CoV-2 Orf3a and E ion channel activity in COVID-19 blood samples

Journal of Clinical and Translational Science(2021)10.1017/cts.2021.856

N/A

0DataRank · unranked

13 citations

Gina Sizemore, Katy Smoot, Peter L. Perrotta, Han‐Gang Yu

Inhibition of SARS-CoV-2 Viral Channel Activity Using FDA-Approved Channel Modulators Independent of Variants

Biomolecules(2022)10.3390/biom12111673

N/A

0DataRank · unranked

5 citations

Gina Sizemore, Iván Martínez, Peter L. Perrotta, Han‐Gang Yu